Megaloblastic anaemia: Diagnosis in a fast and economic way;Anemia megaloblástica: Su estudio en forma rápida y económica

Sangre

Volumn 42, Issue 3, 1997, Pages 235-238

  Marín, Gustavo Horacio ^a,b   Tentoni, Juan ^a   Cicchetti, Guillermo ^a  

^a Hosp Interzonal Gral Agudos S M   (Argentina)

^b HOSPITAL SAN MARTÍN   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

CYANOCOBALAMIN; DIAGNOSTIC AGENT; FOLIC ACID; FORMIMINOGLUTAMIC ACID; HISTIDINE; HOMOCYSTEINE; METHYLMALONIC ACID;

ADOLESCENT; ADULT; ALGORITHM; ARTICLE; BLOOD; COMPARATIVE STUDY; COST CONTROL; CYANOCOBALAMIN DEFICIENCY; DIAGNOSTIC TEST; DIFFERENTIAL DIAGNOSIS; DRUG EFFECT; ECONOMICS; FEMALE; FOLIC ACID DEFICIENCY; HUMAN; MALE; MEGALOBLASTIC ANEMIA; MIDDLE AGED; PREDICTION AND FORECASTING; PREGNANCY; PREGNANCY COMPLICATION; RETICULOCYTE COUNT; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; TIME; URINALYSIS; URINE;

ADOLESCENT; ADULT; ALGORITHMS; ANEMIA, MEGALOBLASTIC; COST CONTROL; DIAGNOSIS, DIFFERENTIAL; DIAGNOSTIC TESTS, ROUTINE; FEMALE; FOLIC ACID; FOLIC ACID DEFICIENCY; FORMIMINOGLUTAMIC ACID; HISTIDINE; HOMOCYSTEINE; HUMANS; MALE; METHYLMALONIC ACID; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; RETICULOCYTE COUNT; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; TIME FACTORS; URINALYSIS; VITAMIN B 12; VITAMIN B 12 DEFICIENCY;

EID: 2442441132     PISSN: 00364355     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Stabler SP, Allen RH, Savage DG, Linderbaum J. Clinical spectrum and diagnosis of cobalamin deficiency. Blood 1990; 76: 871-881.
2. Lindenbaum J. Status of laboratory testing in the diagnosis of megaloblastic anemia. Blood 1983, 61: 624-627.
3. Herbert V. Don't ignore low serum cobalamin levels. Arch Intern Med 1988, 148: 1705-1707.
4. Fairbanks VF. Tests for pernicious anemia: Serum vitamine B12 assay. Mayo Clin Proc 1983; 58: 135-137.
5. Lindenbaum J. Folate and Vit.B12 deficiencies in alcoholism. Semin Hematol 1980; 17: 119-129.
6. Cooper BA, Whitehead VM. Evidence that some patients with pernicious anemia are not recognized by radiodilutions assay for cobalamin serum. N Engl J Med 1978; 229: 816-818.
7. Hall CA, Chu RC. Serum homocysteine in routine evaluation of potential vit.B12 and folate deficiency. Eur J Hematol 1990; 45: 143-149.
8. Chu RC, Hall CA. The total serum homocysteine as an indicator of vit.B12 and folate status. Am J Clin Pathol 1988; 90: 446-449.
9. Stabler SP, Marcell PD, Podell ER, Allen RH, Savage DG, Lindenbaum J. Elevation of total homocysteine in serum of patients with cobalamin or folate deficiency detected by capillary gas chromatography-mass spectrometry. J Clin Invest 1988; 81: 466-474.
10. Curtis D, Sparrow R, Brennan L, Van Der Weyden MB. Elevated serum homocysteine as apredictor for vit. 12 deficiency. Eur J Hematol 1994, 52: 227-232.
11. Allen RH, Stabler SP, Savage DG, Lindenbaum J. Diagnosis of cobalamin deficiency I: Usefulness of serum methylmalonic acid and total homocysteine concentrations. Am J Hematol 1990; 34: 90-98.
12. Lindenbaum J, Savage DG, Stabler SP, Allen RH. Diagnosis of cobalamin deficency II: Sensibity of serum cobalamin, methylmalonic acid and total homocysteine concentrations. Am J Hematol 1990; 34: 99-107.
13. Cox EV, White AM. Methylmalonic acid excretion: An index of vit. B12 deficiency. Lancet 1962; 2: 853-856.
14. Herbert V. Deficiency of cobalamin and neurophychiatric disorders. N Engl J Med 1988; 319: 1733.
15. Luhby AL, Cooperman JM. Folic acid deficiency in man and its relationship with vit.B12. Adv Metab Disord 1964; 1: 263.
16. Gompertz D, Jones JH, Knowles JP. Metabolic precursors of MMA in vit B12 deficiency. Lancet 1967; 41: 424-425.
17. Giorgio AJ, Plaut G. A method for the colorimetric determination of urinary methylmalonic acid in pernicious anemia. J Lab Clin Med 1965; 66: 667.
18. Chanarin I, Bennett MC. A spectrophotometric method for estimulating formiminoglutamic acid and urocanic acid. Br Med J 1962; 1: 27.
19. Zalusky R, Herbert V. Failure of FIGLU excretion distinguish vit B12 deficiency from nutritional folic acid deficiency. J Clin Invest 1961; 40: 1091
20. Carter FC, Heller P, Schaffner G, Korn RJ. Formiminoglutamic acid (FIGLU) excretion in hepatic cirrhosis. Arch Int Med 1961; 108: 41.
21. Merrit AD, Rucknagel DL, Silverman M, Gardiner RC. Urinary urocanic acid in man: The identification of urocanic and the comparative excretions of urocanic acid and N-formiminoglutamic acid after oral histidine in patients with liver disease. J Clin Invest 1961; 41: 1472-1783.
22. Graft E. Análisis de orina. Bs. As. Editorial Panamericana 1987; 204-205.
23. Thomas GF, Howell RR. Selected screening tests for genetic metabolic diseases. Chicago: Year Book Medical Publishers, Inc., 1973.
24. Dacie JV, Lewis SM. Practical hematology. 4th edition, London: Churchill-Livingstone, 1970; 411-412
25. Bennett MC, Chanarin I. Urinary excretion of urocianic and formimino-glutamic acid. Nature 1962; 196: 271-273
26. Dreyfus PM, Dube VE. Clin Chin Acta 1967; 15: 525-528.
27. Sox HC. Probability theory in the use of diagnostic test. Ann Intern Med 1986; 104: 60-66.
28. Kang SS, Wong PWK, Norusis M. Homocysteinemia due to folate deficiency. Metabolism 1987; 36: 458-462.
29. Brattstro L, Israelsson BO, Lindgarde F, Hultberg B. Higher total plasma homocysteine in vit. B12 deficiency than in heterozygocity for homocystinuria due to cystathiorine B-synthase deficiency. Metabo-lism 1988; 37: 175-178.
30. Ermans A, Refsum H, Rupreht J. Cobalamin inactivation during nitrous oxide anesthesia: Effects on homocystine and folate in plasma and urine. In Ermans A. Significance of cobalamin inactivation in normal and malignant hematopoiesis (Thesis) Erasmus University, Rotherdam, 1990.